ALKERMES, INC. for ALKERMES, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Ensure patient access to appropriate medications by limiting the unnecessary use of utilization management policies, including H.R. 2163/S. 464 the Safe Step Act; Policies impacting pharmaceutical development, reimbursement, and patient access and cost; H.R. 5539 - ORPHAN Cures Act; P.L. 115-97 - Tax Cuts and Jobs Act of 2017, Orphan Drug Tax Credit; Awareness of need for transparency and patient access within the 340B program; H.R. 9029 Labor, Health and Human Services, Education Appropriations, 2025; H.R. 9026 Commerce, Justice, Science, and Related Agencies Appropriations, 2025; H.R. 8580 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2025; H.R. 9747 Continuing Appropriations and Extensions Act, 2025 PDUFA Implementation and efficiency improvements at the FDA;
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM PATRICK HIBBS | — |
| MEGAN JACKSON | — |
| ZACHARY MICHAEL MARSHALL | — |
| PETER NORMAN | — |
Alcohol and Drug Abuse ALC
Expand funding and flexibility to address all substance use disorders;
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM PATRICK HIBBS | — |
| MEGAN JACKSON | — |
| ZACHARY MICHAEL MARSHALL | — |
| PETER NORMAN | — |
Medicare/Medicaid MMM
Patient access and maintain six protected classes for depressions and schizophrenia under Medicare Part D; Inflation Reduction Act of 2022 implementation, Part D redesign phase in for small companies; Medicaid Drug Rebate Program proposed rule Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program;
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN JACKSON | — |
| ZACHARY MICHAEL MARSHALL | — |
| PETER NORMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.